AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Lung Cell Mol Physiol 284: L1063-L1071, 2003. First published February 14, 2003; doi:10.1152/ajplung.00363.2002
1040-0605/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/6/L1063    most recent
00363.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amrani, Y.
Right arrow Articles by Panettieri, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amrani, Y.
Right arrow Articles by Panettieri, R. A., Jr.
Vol. 284, Issue 6, L1063-L1071, June 2003

IFN-gamma inhibits human airway smooth muscle cell proliferation by modulating the E2F-1/Rb pathway

Yassine Amrani1, Omar Tliba1, Divaker Choubey2, Chien-Da Huang1, Vera P. Krymskaya1, Andrew Eszterhas1, Aili L. Lazaar1, and Reynold A. Panettieri Jr.1

1 Pulmonary, Allergy, and Critical Care Division, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104; and 2 Department of Radiation Oncology, Stritch School of Medicine, Loyola University Medical Center, Maywood, Illinois 60153

Elucidating the factors that inhibit the increase in airway smooth muscle (ASM) mass may be of therapeutic benefit in asthma. Here, we investigated whether interferon-gamma (IFN-gamma ), a potent inducer of growth arrest in various cell types, regulates mitogen-induced ASM cell proliferation. IFN-gamma (1-100 U/ml) was found to markedly decrease both DNA synthesis and ASM cell number induced by the mitogens epidermal growth factor (EGF) and thrombin. Interestingly, IFN-gamma had no effect on mitogen-induced activation of three major mitogenic signaling pathways, phosphatidylinositol 3-kinase, p70S6k, or mitogen-activated protein kinases. Mitogen-induced expression of cell cycle regulator cyclin D1 was increased by IFN-gamma , whereas no effect was observed on degradation of p27Kip1. Expression array analysis of 23 cell cycle-related genes showed that IFN-gamma inhibited EGF-induced increases in E2F-1 expression, whereas induction of c-myc, cyclin D2, Egr-1, and mdm2 were unaffected. Induction of E2F-1 protein and Rb hyperphosphorylation after mitogen stimulation was also suppressed by IFN-gamma . In addition, IFN-gamma decreased activation of cdk2 and expression of cyclin E, upstream signaling molecules responsible for Rb hyperphosphorylation in the late G1 phase. IFN-gamma also increased levels of IFI 16 protein, whose mouse homolog p202 has been associated with growth inhibition. Together, our data indicate that IFN-gamma is an effective inhibitor of ASM cell proliferation by blocking transition from G1-to-S phase by acting at two different levels: modulation of cdk2/cyclin E activation and inhibition of E2F-1 gene expression.

cytokines; airway remodeling; signal transduction; airway smooth muscle hyperplasia


This article has been cited by other articles:


Home page
 J. Exp. Med.Home page
M. Okamoto, K. Takeda, A. Joetham, H. Ohnishi, H. Matsuda, C. H. Swasey, B. J. Swanson, K. Yasutomo, A. Dakhama, and E. W. Gelfand
Essential role of Notch signaling in effector memory CD8+ T cell-mediated airway hyperresponsiveness and inflammation
J. Exp. Med., May 12, 2008; 205(5): 1087 - 1097.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
E. A. Goncharova, D. A. Goncharov, A. Chisolm, M. S. Spaits, P. N. Lim, G. Cesarone, I. Khavin, O. Tliba, Y. Amrani, R. A. Panettieri Jr., et al.
Interferon {beta} Augments Tuberous Sclerosis Complex 2 (TSC2)-Dependent Inhibition of TSC2-Null ELT3 and Human Lymphangioleiomyomatosis-Derived Cell Proliferation
Mol. Pharmacol., March 1, 2008; 73(3): 778 - 788.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. M. Fischer, S. Zheng, R. Fan, and J. A. Voynow
Neutrophil elastase inhibition of cell cycle progression in airway epithelial cells in vitro is mediated by p27kip1
Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L762 - L768.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
T. Koya, K. Takeda, T. Kodama, N. Miyahara, S. Matsubara, A. Balhorn, A. Joetham, A. Dakhama, and E. W. Gelfand
RANTES (CCL5) Regulates Airway Responsiveness after Repeated Allergen Challenge
Am. J. Respir. Cell Mol. Biol., August 1, 2006; 35(2): 147 - 154.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
R. Wessely
Interference by interferons: Janus faces in vascular proliferative diseases
Cardiovasc Res, June 1, 2005; 66(3): 433 - 443.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
N. Koga, J.-i. Suzuki, H. Kosuge, G. Haraguchi, Y. Onai, H. Futamatsu, Y. Maejima, R. Gotoh, H. Saiki, F. Tsushima, et al.
Blockade of the Interaction Between PD-1 and PD-L1 Accelerates Graft Arterial Disease in Cardiac Allografts
Arterioscler. Thromb. Vasc. Biol., November 1, 2004; 24(11): 2057 - 2062.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. Zhou, J. Li, A. M. Goldsmith, D. C. Newcomb, D. M. Giannola, R. G. Vosk, E. M. Eves, M. R. Rosner, J. Solway, and M. B. Hershenson
Human Bronchial Smooth Muscle Cell Lines Show a Hypertrophic Phenotype Typical of Severe Asthma
Am. J. Respir. Crit. Care Med., March 15, 2004; 169(6): 703 - 711.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.